SCI & TECH● LOWAug 30 · Aug 30, 2026, 8:01 PM
Bayer’s AskBio completes enrollment in Phase 2 heart failure gene therapy trial
Seeking Alpha Tech · global
Bayer's AskBio has successfully completed patient enrollment for its Phase 2 clinical trial of a gene therapy for heart failure. This marks a significant step in the development of a potential new medical treatment.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH31m agoGermany news: Siemens warns on AI eliminating entry-level jobsDW News [en]SCI & TECH52m agoThe roots of AI fear in the West are cultural, not technologicalNew ScientistSCI & TECH1h agoHe is 18 years old, developed a method to reduce quantum computer errors and won a $25,000 scholarshipClarínSCI & TECH1h agoJapan probe sets course for Mars moonDW News [en]